Results 111 to 120 of about 1,745 (164)

Thyrotoxic Hypokalemic Periodic Paralysis Induced by High-Dose Insulin in an Adolescent Male with Type 1 Diabetes Mellitus.

open access: yesHorm Res Paediatr
Bayrak Demirel O   +8 more
europepmc   +1 more source

Acetazolamide Prophylaxis in Hypokalemic Periodic Paralysis

New England Journal of Medicine, 1968
Abstract When acetazolamide, an agent used to treat hyperkalemic periodic paralysis, was inadvertently found to relieve a patient with the hypokalemic variety, he and another patient were observed to compare this agent with conventional therapy. Well tolerated doses of acetazolamide, 375 to 500 mg daily, eliminated severe attacks and were much more ...
Griggs Robert C   +2 more
exaly   +3 more sources

Hypokalemic Periodic Paralysis

Consultant, 2023
Abstract The review chapter on hypokalemic periodic paralysis (HypoPP) examines the epidemiology, genetic basis, and pathophysiology of this rare hereditary channelopathy. It discusses diagnostic considerations, prevention, and treatment options, including the role of acetazolamide.
Brett Simmons, David Matteson
openaire   +2 more sources

Hypokalemic Periodic Paralysis

Southern Medical Journal, 1984
Hypokalemic periodic paralysis is an unusual disease that may begin dramatically. Although terrifying to the patient, the attacks can usually be controlled if the proper diagnosis is made. Although much has been done to determine the pathogenesis, many questions remain unanswered.
V, Johnson, W W, Winternitz
openaire   +2 more sources

Home - About - Disclaimer - Privacy